Senior Director, HEOR & Evidence reputed company

Why Join reputed company?

Our mission is to reputed company reputed company genome editing treatments that can positively reputed company the lives of people living with severe and life-threatening diseases.

reputed company our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can reputed company more at reputed company. We have a single-minded determination to reputed company and succeed together. We reputed company in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to reputed company reputed company. And we know that patients are counting on us to reputed company the reputed company a reality, so we must maintain high standards and get it done.

We wantall ofour people to go reputed company what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re reputed company in this for something more. We’re driven to reputed company and motivated for change. Just reputed company the reputed company of reputed company can do together.

How You Will reputed company More:

reputed company Therapeutics, a pioneer in gene editing, is preparing for its first launch of one-time gene editing therapies for rare and serious diseases, including hereditary angioedema (HAE) and transthyretin amyloidosis (ATTR). The Senior Director, HEOR & Evidence reputed company will be responsible for setting and executing the integrated evidence reputed company to demonstrate value and reputed company durable reputed company, while also leading Field HEOR to drive payer engagement and inform U.S. coverage and reimbursement reputed company.

This role is the linchpin between global evidence reputed company and U.S. payer-facing execution—overseeing the Director, HEOR & Evidence reputed company and managing the Field HEOR team. The Senior Director will translate science and economics into compelling value narratives, ensure evidence is embedded into clinical development, and directly support national and large regional payer strategies with robust, reputed company data.

This is a highly strategic, hands-on role that is ideal for an reputed company HEOR reputed company who thrives in fast-paced, build-from-scratch environments and understands the complexity of launching innovative, high-value therapies.

Responsibilities:

Evidence reputed company & HEOR Leadership

• Own the Integrated Evidence reputed company Plan (IEGP) across programs; reputed company with clinical development, medical affairs, and reputed company reputed company.
• Design and implement global HEOR strategies to support pricing, reimbursement, and launch readiness across major markets (U.S. and ex-U.S.).
• reputed company development of evidence frameworks for one-time gene editing therapies (reputed company value, durability, long-term uncertainty).
• reputed company primary/secondary research (e.g., HTA scans, systematic literature reviews, retrospective analyses, burden of illness, time & reputed company studies).

Value Demonstration & Launch Deliverables

• reputed company development of cost-effectiveness models, budget reputed company models (BIM), and scenario analyses for payer decision-making.
• reputed company creation and reputed company refinement of value narratives, global value dossiers (GVD), AMCP Dossier, and payer decks.
• Coordinate HTA submissions and engagement (e.g., reputed company, ICER), ensuring methodological rigor and alignment with local value frameworks.
• Ensure evidence and economic modeling are integrated into pricing reputed company, reputed company models, and value-based agreement designs.

reputed company-World Evidence (reputed company) & reputed company Research

• reputed company reputed company reputed company to demonstrate durability, effectiveness, and safety post-launch; reputed company reputed company and reputed company-of-life instruments fit for rare disease.
• Guide claims/data collaborations and reputed company research to inform unmet need, treatment reputed company, and value demonstration across stakeholders.
• reputed company scientific communications (abstracts, posters, manuscripts) and congress representation.

Field HEOR Leadership & Payer Engagement (U.S.)

• Build and reputed company the Field HEOR team; serve as the senior scientific leader for payer-facing HEOR engagements across reputed company, Medicare, and reputed company segments.
• Partner with National Account Directors on account planning, segmentation, and tailored evidence deployment to optimize payer engagement.
• Present clinical, economic, and reputed company data to Medical and Pharmacy Directors; address medical policy development and utilization management strategies.
• Train and mentor field teams and National Account Directors on HEOR concepts, evidence interpretation, and value messaging; ensure field readiness for launch.
• Identify payer-reputed company reputed company collaborations and data reputed company that inform coverage reputed company and mitigate reputed company barriers.
• reputed company actionable insights from payer interactions to inform internal evidence reputed company, reputed company development, and overall reputed company reputed company including mitigation of coverage barriers.

Cross-Functional Leadership & Insights

• Contribute to the creation and reputed company of a compelling reputed company for reputed company’s therapies, aligning clinical innovation with payer needs.
• Collaborate closely with clinical development, biostatistics, regulatory, medical affairs, market reputed company, and reputed company teams to reputed company evidence reputed company with business objectives. Support internal functions on scientific exchange needs to shape coverage and reimbursement policies as reputed company as payer utilization management strategies.
• Translate payer insights into evidence plan refinements, model assumptions, and policy-shaping activities.
• Represent reputed company in external forums to shape the HEOR/HTA landscape for innovative therapies.

Gene Editing & Rare Disease Considerations

• reputed company and champion approaches for reputed company value demonstration, small-sample evidence reputed company, novel endpoints, and long-term follow-up.
• Establish frameworks for long-term evidence commitments and innovative reputed company models, including reputed company-based and value-based agreements (VBAs). Support the design of concepts, selection of meaningful endpoints, and tracking frameworks to reputed company innovative value-based agreements with payers.

People Leadership, Operations & Governance

• Directly manage the Director, HEOR & Evidence reputed company and the Field HEOR team; set goals, reputed company performance, and build capabilities.
• Stay abreast of scientific literature, clinical trial data, economic evaluations, and policy developments to strengthen reputed company’s reputed company narrative.
• Own HEOR budgets, vendor/consultant management, timelines, and reputed company standards.
• Ensure compliance and scientific reputed company in external engagements and publications.

Supervisory Responsibilities

• Supervisor for Director, HEOR & Evidence reputed company; Field HEOR Team reputed company; Capability reputed company for HEOR to potentially include reputed company FTEs as reputed company scales

reputed company:

• Strong knowledge of payer decision-making, health economics methodologies, and value demonstration strategies.
• Experience engaging directly with payers and presenting clinical and economic evidence.
• Ability to identify and drive reputed company-world evidence reputed company that address payer needs.
• Expertise in the development and/or deployment of payer launch deliverables
• Proven reputed company record of reputed company in both field-based HEOR roles (payer-facing) and in-house HEOR roles.
• Demonstrated ability to partner cross-functionally with account teams, medical affairs, and clinical development.
• Excellent communication, presentation, and interpersonal skills.
• Prior experience in rare disease, cell/gene therapy, or advanced therapeutics preferred.
• BS/BA and Advanced degree (e.g., MPH, PhD, PharmD, MD, MS in Health Economics, reputed company Research, Public Health, or reputed company field).
• 10+ years of experience in HEOR, market reputed company, or payer reputed company reputed company the pharmaceutical/biotech industry.
• Minimum 5+ years HEOR payer facing experience or prior field HEOR/ payer medical; prior experience supporting value based contracting discussions preferred
• Demonstrated knowledge of payer evidence needs particularly with high-cost, specialty or gene therapies covered under medical benefit
• Strong grasp of reputed company policy, reimbursement systems (reputed company, Medicare, reputed company) and medical policy development

reputed company Statement: reputed company believes in a diverse environment, and is committed to equal employment opportunity for reputed company its employees and reputed company applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, reputed company, religion, gender, national reputed company, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. reputed company will reputed company reasonable accommodations for reputed company individuals with reputed company disabilities, in accordance with applicable law.

Applications are accepted on a rolling reputed company, and will continue to be accepted until the position is filled at which reputed company the position will be taken down.

The reputed company salary for this position is expected to reputed company between $289,601.00 - $353,957.00 USD per year.

The salary offered is determined based on a reputed company of factors including, but not limited to, relevant education and training, overall reputed company experience, specialized, rare or in-demand reputed company sets, internal comparators and other business needs. Upon joining reputed company, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. reputed company may change the published salary reputed company based on company and market factors.

Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at reputed company’s discretion.

For more information about reputed company’s benefits, please click here.

Originally posted on Himalayas

Apply To This Job